TrippBio

BETA

TrippBio is developing a new, therapeutic application of an FDA-approved drug with a high probability to be proven safe and efficacious in the treatment and prevention of the SARS-CoV-2 virus that causes COVID-19.

Analytics

Raised to Date: $13,300

Aggregate Commitments $
Platform

Netcapital

Start Date

09/16/2020

Close Date

11/16/2020

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

Equity - Common

Funding Type

RegCF

Series

Pre-Seed

Pre-Money Valuation

$5,255,840

Weekly Commitments $
Status

Active

Reporting Date

09/16/2020

Days Remaining

58

% of Min. Goal

133%

% of Max. Goal

1%

Likelihood of Max
Avg. Daily Raise

$13,300

Momentum
Location

Jacksonville, Florida

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Business Type

Growth

TrippBio, with a post-money valuation of $7.1 million, is raising funds on NetCapital. The company is developing a new therapeutic application of an FDA-approved drug for the treatment and prevention of the SARS-CoV-2 virus. The company believes that the drug TD213 is capable of preventing the host cell from assembling the virus that causes COVID-19. Billy Meadow and Richard Still founded TrippBio in May 2020. The current round of crowdfunding has a minimum raise of $10,000 and a maximum raise of $1,070,000, and the funds will be used for initial clinical trial, development and manufacturing of TD213, marketing and advertising, professional services, and ramp-up clinical trial. TrippBio is well-positioned to help the world combat COVID-19 and other infectious diseases.

Other Deals

UpLyft on Wefunder

UpLyft has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
HealtheMed on Wefunder

HealtheMed has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Millennial Fertility Co. on NetCapital

The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…

Crowd
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add TrippBio on NetCapital
Follow company
Follow TrippBio on NetCapital